Puma Biotechnology Analyst Price Targets

Wall Street analyst price targets and consensus rating for Puma Biotechnology (PBYI).

Price Target Range — 6 Quarters

Analyst Consensus — 2 Analysts

1Buy

1Hold

Consensus RatingBuy# Analysts2Avg. Consensus PT$7Upside to Avg. PT-39.2%

Rating Trend — Last 9 Months

Recent Analyst Actions

모든 평가 보기 →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 7, 2026	TD Cowen	Marc Frahm	PT Raise	Hold	$5→$6
Feb 28, 2025	HC Wainwright & Co.	Edward White	Maintained	Buy	$7
Dec 23, 2024	HC Wainwright & Co.	Edward White	Maintained	Buy	$7
Nov 20, 2024	HC Wainwright & Co.	Edward White	Maintained	Buy	$7
Nov 8, 2024	HC Wainwright & Co.	Edward White	Maintained	Buy	$7
Aug 2, 2024	HC Wainwright & Co.	Edward White	Maintained	Buy	$7
Jul 26, 2024	HC Wainwright & Co.	Edward White	Maintained	Buy	$7
Jun 4, 2024	HC Wainwright & Co.	Edward White	Maintained	Buy	$7
Jun 3, 2024	HC Wainwright & Co.	Edward White	Maintained	Buy	$7
May 20, 2024	HC Wainwright & Co.	Edward White	Maintained	Buy	$7
May 3, 2024	HC Wainwright & Co.	Edward White	Maintained	Buy	$7
Mar 1, 2024	HC Wainwright & Co.	Edward White	PT Cut	Buy	$8→$7
Feb 13, 2024	HC Wainwright & Co.	Edward White	Maintained	Buy	$8

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
TD Cowen Maintains Hold on Puma Biotechnology, Raises Price Target to $6

TD Cowen analyst Marc Frahm maintains Puma Biotechnology (NASDAQ:PBYI) with a Hold and raises the price target from $5 to $6.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Puma Biotechnology, Maintains $7 Price Target

HC Wainwright & Co. analyst Edward White reiterates Puma Biotechnology (NASDAQ:PBYI) with a Buy and maintains $7 price target.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Puma Biotechnology, Maintains $7 Price Target

HC Wainwright & Co. analyst Edward White reiterates Puma Biotechnology (NASDAQ:PBYI) with a Buy and maintains $7 price target.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Puma Biotechnology, Maintains $7 Price Target

HC Wainwright & Co. analyst Edward White reiterates Puma Biotechnology (NASDAQ:PBYI) with a Buy and maintains $7 price target.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Puma Biotechnology, Maintains $7 Price Target

HC Wainwright & Co. analyst Edward White reiterates Puma Biotechnology (NASDAQ:PBYI) with a Buy and maintains $7 price target.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Puma Biotechnology, Maintains $7 Price Target

HC Wainwright & Co. analyst Edward White reiterates Puma Biotechnology (NASDAQ:PBYI) with a Buy and maintains $7 price target.

Benzinga Newsdesk

Puma Biotechnology Inc

뉴스

파트너 / 기고자

벤징가 글로벌

Puma Biotechnology Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
TD Cowen Maintains Hold on Puma Biotechnology, Raises Price Target to $6

PRO
HC Wainwright & Co. Reiterates Buy on Puma Biotechnology, Maintains $7 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on Puma Biotechnology, Maintains $7 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on Puma Biotechnology, Maintains $7 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on Puma Biotechnology, Maintains $7 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on Puma Biotechnology, Maintains $7 Price Target

People Also Watch

People Also Watch

Puma Biotechnology Inc

뉴스

파트너 / 기고자

벤징가 글로벌

Puma Biotechnology Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROTD Cowen Maintains Hold on Puma Biotechnology, Raises Price Target to $6

PROHC Wainwright & Co. Reiterates Buy on Puma Biotechnology, Maintains $7 Price Target

PROHC Wainwright & Co. Reiterates Buy on Puma Biotechnology, Maintains $7 Price Target

PROHC Wainwright & Co. Reiterates Buy on Puma Biotechnology, Maintains $7 Price Target

PROHC Wainwright & Co. Reiterates Buy on Puma Biotechnology, Maintains $7 Price Target

PROHC Wainwright & Co. Reiterates Buy on Puma Biotechnology, Maintains $7 Price Target

People Also Watch

People Also Watch

PRO
TD Cowen Maintains Hold on Puma Biotechnology, Raises Price Target to $6

PRO
HC Wainwright & Co. Reiterates Buy on Puma Biotechnology, Maintains $7 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on Puma Biotechnology, Maintains $7 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on Puma Biotechnology, Maintains $7 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on Puma Biotechnology, Maintains $7 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on Puma Biotechnology, Maintains $7 Price Target